Online inquiry

IVTScrip™ mRNA-Human ACSM2B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14252MR)

This product GTTS-WK14252MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ACSM2B protein. This product can be used in B cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001105069.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 348158
UniProt ID Q68CK6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACSM2B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14252MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK18465MR IVTScrip™ mRNA-Human AMZ2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AMZ2
GTTS-WK23337MR IVTScrip™ mRNA-Human ATAD2B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATAD2B
GTTS-WK8552MR IVTScrip™ mRNA-Human ACSM2B, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ACSM2B
GTTS-WK4173MR IVTScrip™ mRNA-Human CD203c, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CD203c
GTTS-WK9213MR IVTScrip™ mRNA-Human ADARB1, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADARB1
GTTS-WK21476MR IVTScrip™ mRNA-Human ANG, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANG
GTTS-WK9516MR IVTScrip™ mRNA-Human ADAT2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAT2
GTTS-WK19664MR IVTScrip™ mRNA-Human AMYP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AMYP1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →